Preview Posting of COVID‐19 Vaccine Codes and Crosswalks to be used for Non‐US vaccine administration. All COVID‐19 related CVX codes are associated to the Vaccine Group "COVID‐19". CVX and MVX codes are identified for vaccines that have received emergency authorization from the World Health Organization (WHO), US Food and Drug Administration (FDA) or both. CVX codes have also been added without associated MVX for vaccines that are manufactured and administered outside the US but which have not been authorized by the WHO. The list of vaccines not authorized by the WHO may be incomplete. The list of vaccines indicated to be WHO‐authorized will be updated periodically as the CDC monitors WHO published information.

CVX CVX Long Description CVX Short Description CVX Note CVX Status MVX Code MVX Manufacturer Product Tradename(s) Code SARS‐COV‐2 (COVID‐19) vaccine, mRNA, spike EUA 12/18/2020, 2‐dose vaccine. Used to record Moderna COVID‐19, mRNA, LNP‐S, PF, 100 mcg/0.5 mL Moderna COVID‐19 Vaccine (non‐ 207 protein, LNP, preservative free, 100 mcg/0.5mL vaccines administered in the US and in non‐US locations Active MOD Moderna US, Inc. dose US Spikevax) dose (includes tradename Spikevax) EUA 12/11/2020, 2‐dose vaccine. Used to record Pfizer SARS‐COV‐2 (COVID‐19) vaccine, mRNA, spike COVID‐19, mRNA, LNP‐S, PF, 30 mcg/0.3 mL Pfizer‐BioNTech COVID‐19 Vaccine 208 vaccines administered in the US and in non‐US locations Active PFR Pfizer, Inc protein, LNP, preservative free, 30 mcg/0.3mL dose dose (Non‐US COMIRNATY) (includes tradename Comirnaty) Potential EUA, 2‐dose vaccine. AstraZeneca vaccine is SARS‐COV‐2 (COVID‐19) vaccine, vector non‐ AstraZeneca COVID‐19 Vaccine COVID‐19 vaccine, vector‐nr, rS‐ChAdOx1, PF, authorized by the WHO and recognized towards immunity in 210 replicating, recombinant spike protein‐ChAdOx1, Non‐US ASZ AstraZeneca (Non‐US tradenames include 0.5 mL the US. Non‐US WHO authorized tradenames/identifiers preservative free, 0.5 mL VAXZEVRIA, COVISHIELD) include VAXZEVRIA, AZD1222, ChAdOx1 nCoV‐19, COVISHIELD SARS‐COV‐2 (COVID‐19) vaccine, vector non‐ COVID‐19 vaccine, vector‐nr, rS‐Ad26, PF, 0.5 EUA 02/27/2021, 1‐dose vaccine. Used to record Janssen/J&J 212 replicating, recombinant spike protein‐Ad26, Active JSN Janssen Janssen (J&J) COVID‐19 Vaccine mL vaccines administered in the US and in non‐US locations preservative free, 0.5 mL SARS‐COV‐2 COVID‐19 Inactivated Virus Non‐US COVID‐19 IV Non‐US Vaccine (BIBP, WHO authorized pandemic vaccine. Recognized towards Sinopharm (BIBP) COVID‐19 510 Non‐US SPH Sinopharm‐Biotech Vaccine Product (BIBP, Sinopharm) Sinopharm) immunity in US Vaccine SARS‐COV‐2 COVID‐19 Inactivated Virus Non‐US COVID‐19 IV Non‐US Vaccine (CoronaVac, WHO authorized pandemic vaccine. Recognized towards Coronavac (Sinovac) COVID‐19 511 Non‐US SNV Sinovac Vaccine Product (CoronaVac, Sinovac) Sinovac) immunity in US Vaccine SARS‐COV‐2 COVID‐19 Non‐US Vaccine, Specific Pandemic Non‐US Covid Administration ‐ specific CVX or 500 COVID‐19 Non‐US Vaccine, Product Unknown Non‐US Product Unknown product unknown SARS‐COV‐2 COVID‐19 Inactivated Virus Non‐US Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 501 COVID‐19 IV Non‐US Vaccine (QAZCOVID‐IN) Non‐US Vaccine Product (QAZCOVID‐IN) counted toward immunity in US SARS‐COV‐2 COVID‐19 Inactivated Virus Non‐US Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 502 COVID‐19 IV Non‐US Vaccine (COVAXIN) Non‐US Vaccine Product (COVAXIN) counted toward immunity in US SARS‐COV‐2 COVID‐19 Live Attenuated Virus Non‐ Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 503 COVID‐19 LAV Non‐US Vaccine (COVIVAC) Non‐US US Vaccine Product (COVIVAC) counted toward immunity in US SARS‐COV‐2 COVID‐19 Viral Vector Non‐replicating Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 504 COVID‐19 VVnr Non‐US Vaccine (Sputnik Light) Non‐US Non‐US Vaccine Product (Sputnik Light) counted toward immunity in US

SARS‐COV‐2 COVID‐19 Viral Vector Non‐replicating Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 505 COVID‐19 VVnr Non‐US Vaccine (Sputnik V) Non‐US Non‐US Vaccine Product (Sputnik V) counted toward immunity in US

SARS‐COV‐2 COVID‐19 Viral Vector Non‐replicating COVID‐19 VVnr Non‐US Vaccine (CanSino Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 506 Non‐US Vaccine Product (CanSino Biological Biological Inc./Beijing Institute of Non‐US counted toward immunity in US Inc./Beijing Institute of Biotechnology Biotechnology) SARS‐COV‐2 COVID‐19 Protein Subunit Non‐US COVID‐19 PS Non‐US Vaccine (Anhui Zhifei Vaccine Product (Anhui Zhifei Longcom Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 507 Longcom Biopharmaceutical + Institute of Non‐US Biopharmaceutical + Institute of Microbiology, counted toward immunity in US Microbiology, Chinese Academy of Sciences Chinese Academy of Sciences) SARS‐COV‐2 COVID‐19 Protein Subunit Non‐US COVID‐19 PS Non‐US Vaccine (Jiangsu Province Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 508 Vaccine Product (Jiangsu Province Centers for Non‐US Centers for Disease Control and Prevention) counted toward immunity in US Disease Control and Prevention) SARS‐COV‐2 COVID‐19 Protein Subunit Non‐US Pandemic Non‐US Vaccine not Authorized by WHO ‐ not 509 COVID‐19 PS Non‐US Vaccine (EpiVacCorona) Non‐US Vaccine Product (EpiVacCorona) counted toward immunity in US